BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Melanoma Institute Australia
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260805
DTEND;VALUE=DATE:20260808
DTSTAMP:20260526T130802
CREATED:20260331T012114Z
LAST-MODIFIED:20260331T012114Z
UID:10000279-1785888000-1786147199@melanoma.org.au
SUMMARY:MOGA Annual Scientific Meeting
DESCRIPTION:The 2026 MOGA Annual Scientific Meeting (ASM) will bring together Australian medical oncologists to reflect on a timely theme: \nReimagining Cancer Care: Is Less Doing More? \nIn recent years\, oncology has found itself at a fascinating crossroads. With ever-deepening insights into tumour biology\, immunotherapy\, molecular profiling\, and patient-centred care\, we are beginning to ask a powerful and\, at times\, uncomfortable question: Are we sometimes doing too much? \nWe are now confronting the possibility that treatment de-escalation is not just a compromise\, but potentially a pathway to more humane\, precise\, and effective care. This conversation extends well beyond protocols and guidelines. It challenges us to think deeply about patient autonomy\, shared decision-making\, and what quality of life truly means in the era of personalised medicine. \nThis ASM will bridge disciplines and perspectives—from surgical oncology to medical and radiation oncology\, to palliative care and psychosocial support. We will consider not only clinical evidence\, but also the ethical\, logistical\, and emotional dimensions of doing less. We will look at emerging biomarkers and novel drug targets that allow us to fine-tune therapy like never before. Exploring what it means to personalise care in the truest sense—not just through science\, but through listening. \nLocation: RACV Royal Pines\, Gold Coast\, Australia \nKey Dates: \nEarly Bird Registrations Close: 14 June 2026\nAbstract Submissions Close: 14 June 2026\nAbstract Selection Advice: 3 July 2026\nAbstract Acceptance by Presenter: 10 July 2026\nTravel Award Applications Open: 3 July 2026\nTravel Award Applications Close: 10 July 2026\nTravel Award Recipient Notification: 17 July 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/moga-annual-scientific-meeting/
LOCATION:RACV Royal Pines Resort\, Ross Street\, Gold Coast\, Queensland\, 4217\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/MOGA-Asm-600-x-338-px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260526T130802
CREATED:20260505T060732Z
LAST-MODIFIED:20260505T060732Z
UID:10000293-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF Genomics Health Futures
DESCRIPTION:The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \nStream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy. \nStream 2 (TCR): conduct scalable research to enhance novel gene discoveries\, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies. \nStream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease\, diabetes and other common and/or complex diseases). \nStream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer\, colorectal cancer\, prostate cancer and other common cancers) \nStream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice. \nStream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing\, portability\, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical\, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics. \nApplicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan. \nKey Dates \n\nMinimum data due date: 22 July 2026\nApplications close: 19 August 2026\nIndicative funding status: Funding anticipated to be awarded from June 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-genomics-health-futures/
LOCATION:Tasmania
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-Genomics-Health-Futures600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260830
DTEND;VALUE=DATE:20260831
DTSTAMP:20260526T130802
CREATED:20251016T032249Z
LAST-MODIFIED:20251024T040143Z
UID:10000208-1788048000-1788134399@melanoma.org.au
SUMMARY:2026 TCS Sydney Marathon presented by ASICS
DESCRIPTION:Whether you’re chasing your debut or your next star\, the TCS Sydney Marathon presented by ASICS is your moment to shine. \nSydney is the bucket-list race that redefines what’s possible\, so come experience the place where the world comes to finish. \nWhen you nominate MIA as your charity of choice\, funds raised support our life-saving melanoma research\, so we can reach our mission of zero deaths from melanoma. \nMake sure you set up your fundraising page\, as well as registering for the event – both can be done at the link below. \nREGISTER NOW
URL:https://melanoma.org.au/event/2026-tcs-sydney-marathon-presented-by-asics/
LOCATION:Tasmania
CATEGORIES:Fundraiser,Running Events
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/06/TCS-Sydney-Marathon-2025.jpg
END:VEVENT
END:VCALENDAR